New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
DataRobot Launches its First AI Investment Workflow with FactSet
-
DataRobot Launches its First AI Investment Workflow with FactSet
-
3-V Biosciences Changes Name to Sagimet Biosciences and Closes $25 Million Financing
-
Twilio Announces Second Quarter 2019 Results
-
Form SC 13D Mirum Pharmaceuticals, Filed by: New Enterprise Associates 16, L.P.
-
Fugue and New Light Technologies Partner to Better Secure the Public Cloud
-
MindTickle Raises $40 Million in Series C Funding to Accelerate Customer-facing Capabilities of Global Organizations
-
Magenta Medical Closes Funding Round Led by NEA in Its First-Ever Life Sciences Investment in Israel
-
Turning Point Therapeutics Inc. (TPTX) Announces Carol Gallagher, Pharm.D. to Board
-
Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors
-
Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors
-
Heap Raises $55 Million in Series C Funding
-
Radiology Partners Receives $700 Million Investment from Starr Investment Holdings
-
CIT GAP Funds Makes Follow-On Investment in 4stay to Support Rapid Growth
-
Eargo Continues Momentous Growth With New CFO, CMO, and VP of Software Engineering
-
Fugue Announces Support for Microsoft Azure, Delivering Unified Multi-Cloud Security and Compliance
-
DataRobot Launches AI for Good: Powered by DataRobot
-
Topia Expands Leadership Team with Two Customer-Focused Executives
-
Parvus Therapeutics Announces Key Executive and Board of Directors Appointments
-
Form SC 13D/A Epizyme, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
-
OmniSci and Disaster Intelligence Announce Strategic Partnership to Expand Offerings in Public Sector
-
Topia Named "Hot Vendor" in Global Mobility Management by Aragon Research
-
Lega Nazionale Pallacanestro & ViewLift Announce Video Streaming Alliance
-
OmniSci Announces Partnership with Core Scientific
-
DataRobot Appoints Rob Hegarty to General Manager of Financial Markets and Fintech
-
Twilio (TWLO) Announces Jeff Immelt to Board
-
Twilio Welcomes Jeff Immelt to Twilio Board of Directors
-
DataRobot Acquires MLOps Pioneer and Category Leader, ParallelM
-
Desktop Metal Now Shipping the World’s First Office-Friendly Metal 3D Printing System to Companies Throughout Europe
-
PsiKick Rebrands to Everactive; Announces Next-Generation Products; Raises $30M to Grow Batteryless Solutions for Industrial Internet of Things
-
CIT’s Virginia Founders Fund Invests in Fringe to Change the Way Employers Offer Benefits
-
Introducing Timescale Cloud: The First Fully-Managed, Multi-Cloud Time-Series Database Service
-
Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687
-
Imara Presented Positive, Interim Phase 2a Data on IMR-687 for the Treatment of Sickle Cell Disease at the 24th Congress of the European Hematology Association
-
SetPoint Medical Reports Positive Results from its U.S. Pilot Study in Rheumatoid Arthritis
-
Qpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
-
Form SC 13D/A Nightstar Therapeutics Filed by: New Enterprise Associates 15, L.P.
-
NEA Promotes Lily Huang to Principal
-
Databricks and Booz Allen Team to Bring Unified Analytics to US Government Clients
-
Aquabyte Raises $10 Million Series A Financing to Continue Leading the Transformation of the Fish Farming Industry with Machine Learning
-
Regulus Therapeutics (RGLS) Appoints Jake Nunn and Simos Simeonidis, Ph.D. to Board
-
Regulus Announces New Additions to Board of Directors
-
Imara to Present at the 24th Congress of the European Hematology Association
-
Horizon Healthcare Services, Inc., Partners with Aetion to Improve Treatment Pathways Using Predictive Modeling and Machine Learning
-
Fugue Releases Unified SaaS Product for Autonomous Cloud Infrastructure Security & Compliance
-
SetPoint Medical to Present Results From The U.S. Pilot Study in Rheumatoid Arthritis Patients at European Congress of Rheumatology (EULAR) 2019
-
DataRobot Appoints Hilarie Koplow-McAdams to its Board of Directors
-
Fugue Adds SOC 2 and ISO 27001 to its Autonomous Cloud Compliance Solution
-
OmniSci Accelerates International Momentum, Hires Allison Searle as Vice President of Sales in EMEA

